The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?

Overview of attention for article published in Frontiers in immunology, October 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 1 news outlet

twitter: 16 X users

Citations

dimensions_citation: 142 Dimensions

Readers on

mendeley: 247 Mendeley

Summary News X Dimensions citations

So far, Dimensions has found 142 publications that cite this research output.

142

The most recent citing publications are shown below. View all 142 publications that cite this research output on Dimensions.

Immune Checkpoint Inhibitors in Cancer Treatment and Incidence of Pancreatitis

Article in Cureus (August 2024)

Onco-Primary Care of Patients Receiving Immune Checkpoint Inhibitors

Article in The American Journal of Medicine (August 2024)

The role of immune checkpoint inhibitors and/or Yttrium-90 radioembolization in the management of hepatocellular carcinoma: challenges of treatment sequence

Article in Hepatoma Research (August 2024)